Organization
Shire Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Shire Plc
... to Cambridge and evaluating space needs ahead of its planned purchase of Shire next year. That combined company could wind up at 500 Kendall — ...
... planned for years. RELATED:The top 10 drugmakers of 2024 - 5. Sanofi Shire had previously planned to take over the lease of the old Genzyme ...
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... subcutaneously every week, two weeks or four weeks. RELATED:New Roche threat to Shire's hemophilia franchise? CEO Ornskov says he's not worried But Hemlibra's prospects don't ...
... It's no secret that Takeda's pending Shire megadeal has plenty of critics, and some of them have penned a ...
... Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company'), in accordance with 5.6.1R of the ...
... companiesthat are the major players in the next-generation antibody therapies market: · Shire plc · Seattle Genetics, Inc. · Sanofi · Roche · Pfizer, Inc. ...
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... panel of industry experts from several organisations including VisitScotland, Aberdeen City and Shire Tourism Awards, Highlands Islands Tourism Awards, the Association of Scottish Visitor Attractions ...
... to allow Japanese drug maker Takeda Pharmaceutical's $62bn (£47.5bn) takeover of London-listed Shire, the European Commission has said. The EU competition enforcer can give the ...
Subscribe now for full coverage on Shire Plc
Start My Free Trial